For the Inventor, By the Inventor

Enter assignee name

Stockholm, Sweden

Ab Kabi

Calculating rank

USPTO Granted Patents = 30

Forward Citations = 772

Loading Chart...

Loading Chart...

49 inventors (with patents filed for the assignee):

Karl G Claeson (11 out of 17 patents)

Leif E Aurell (8 out of 11 patents)

Lembit Mikiver (4 out of 5 patents)

4. Pinchas Moses (4 out of 7 patents)

5. Nils Ake Jonsson (4 out of 4 patents)

6. Lars-Olov Andersson (4 out of 5 patents)

7. Bo T Af Ekenstam (4 out of 6 patents)

8. Birgitta G Karlsson (4 out of 4 patents)

9. Nils A Jonsson (3 out of 4 patents)

10. Ferenc Merenyi (3 out of 4 patents)

11. Leif R Simonsson (3 out of 6 patents)

12. Knut Oivind Uthne (2 out of 2 patents)

13. Hans Uno Sievertsson (2 out of 2 patents)

14. Lars-Erik Westlund (2 out of 2 patents)

15. Gudrun M Einarsson (2 out of 2 patents)

Core Competencies:

Serine Proteases

Chromogenic Substrates

Thrombin Substrates

Tripeptide Derivatives

Growth Promoting Peptides

Antithrombotic Compounds

Hepatitis Virus Methods

Biochemical Reactions

Polypeptides

Coagulation Factors

Indole Derivatives

Isoquinoline Diones

30 patents: Sort by Forward Citations

1. 4276375 - Determination of serine proteases (1981-06-30),

2. 4252715 - Chromogenic enzyme substrates (1981-02-24),

3. 4247454 - Novel chromogenic thrombin substrates (1981-01-27),

4. 4242329 - Bradykinin-inhibiting tripeptide derivatives (1980-12-30),

5. 4235772 - Novel peptides having growth promoting activity (1980-11-25),

6. 4218476 - Anti-thrombotic N-alkylthioakylamino benzenesulfonamides (1980-08-19),

7. 4218472 - Geminally disubstituted indene derivatives (1980-08-19),

8. 4214049 - Assay of serine proteases using novel chromogenic enzyme substrates (1980-07-22),

9. 4207232 - Specific chromogenic enzyme substrates (1980-06-10),

10. 4172093 - Pharmacodynamically active indan derivatives (1979-10-23),

11. 4169015 - Novel chromogenic thrombin substrates (1979-09-25),

12. 4168300 - Method of removal of hepatitis virus (1979-09-18),

13. 4168146 - Immunoassay with test strip having antibodies bound thereto (1979-09-18),

14. 4162941 - Method for determining a proteolytic enzyme (1979-07-31),

15. 4138287 - Purifying and isolating method for hepatitis virus to use in preparing (1979-02-06),

Company Overview

Ab Kabi is a Stockholm-based company specializing in innovative solutions within the biotechnology sector. The organization focuses on developing advanced medical devices and therapeutic technologies aimed at enhancing patient care and improving health outcomes. With a commitment to research and development, Ab Kabi leverages cutting-edge science to address critical healthcare challenges, positioning itself as a key player in the evolving landscape of medical technology in Europe.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

30 Patents

#31 in Stockholm

#225 in Sweden

#21,924 in the World

Stockholm, Sweden

Ab Kabi

Forward Citations = 772

49 inventors:

Karl G Claeson (11 out of 17 patents)

Leif E Aurell (8 out of 11 patents)

Lembit Mikiver (4 out of 5 patents)

4. Pinchas Moses (4 out of 7 patents)

5. Nils Ake Jonsson (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ab Kabi. Retrieved from https://idiyas.com/company/ab-kabi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…